Big Pharma Still Sees Value In Cell And Gene Therapy’s Next Wave

Drugmakers Seek Partners To Ease Market Challenges

 
• By Mandy Jackson
  
Novartis, Astellas, AstraZeneca and Gilead are among big pharma firms still seeking next wave technologies (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Cell Therapies